Prognostic value and immune infiltration analyses of cuproptosis-related genes in hepatocellular carcinoma

Junjie Li, Shuoyi Ma, Yantao Zheng, Mengchen Qin, Hui Jia, Chang Liu, Yunjia Li, Guanghui Deng, Min Cai, Bin Liu, Lei Gao
{"title":"Prognostic value and immune infiltration analyses of cuproptosis-related genes in hepatocellular carcinoma","authors":"Junjie Li, Shuoyi Ma, Yantao Zheng, Mengchen Qin, Hui Jia, Chang Liu, Yunjia Li, Guanghui Deng, Min Cai, Bin Liu, Lei Gao","doi":"10.15212/amm-2023-0035","DOIUrl":null,"url":null,"abstract":"The role of cuproptosis, a newly discovered form of programmed cell death, remains poorly understood in hepatocellular carcinoma (HCC). This study was aimed at constructing a novel cuproptosis model for analyzing the clinical features, mutation characteristics and immune profile of HCC associated with cuproptosis-related genes (CRG), and to analyze the prognostic value of CRGs in HCC. We comprehensively evaluated HCC datasets containing clinicopathological information from The Cancer Genome Atlas and GEO, on the basis of 19 CRGs. The prognostic value of the cuproptosis-related risk score was established. Our results revealed two clusters associated with cuproptosis. Cluster B exhibited pronounced isolated innate immune cell infiltration and poor prognosis, and significant differences in prognosis and immune infiltration were observed between the groups with high and low cuproptosis risk. High copper mortality risk scores were associated with an elevated tumor mutational burden (TMB) and poor prognosis. Our findings suggest that evaluating copper-death subtypes provides insights into CRGs. Moreover, the copper mortality risk score model aids in characterizing prognosis and immune infiltration independently of the TMB.","PeriodicalId":72055,"journal":{"name":"Acta materia medica","volume":"30 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta materia medica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15212/amm-2023-0035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The role of cuproptosis, a newly discovered form of programmed cell death, remains poorly understood in hepatocellular carcinoma (HCC). This study was aimed at constructing a novel cuproptosis model for analyzing the clinical features, mutation characteristics and immune profile of HCC associated with cuproptosis-related genes (CRG), and to analyze the prognostic value of CRGs in HCC. We comprehensively evaluated HCC datasets containing clinicopathological information from The Cancer Genome Atlas and GEO, on the basis of 19 CRGs. The prognostic value of the cuproptosis-related risk score was established. Our results revealed two clusters associated with cuproptosis. Cluster B exhibited pronounced isolated innate immune cell infiltration and poor prognosis, and significant differences in prognosis and immune infiltration were observed between the groups with high and low cuproptosis risk. High copper mortality risk scores were associated with an elevated tumor mutational burden (TMB) and poor prognosis. Our findings suggest that evaluating copper-death subtypes provides insights into CRGs. Moreover, the copper mortality risk score model aids in characterizing prognosis and immune infiltration independently of the TMB.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肝细胞癌中铜绿相关基因的预后价值及免疫浸润分析
cuprotosis是一种新发现的程序性细胞死亡形式,其在肝细胞癌(HCC)中的作用仍知之甚少。本研究旨在构建一种新的铜质增生模型,分析与铜质增生相关基因(cuprotosis - associated genes, CRG)相关的HCC的临床特征、突变特征和免疫谱,并分析CRG在HCC中的预后价值。基于19个CRGs,我们综合评估了包含癌症基因组图谱和GEO临床病理信息的HCC数据集。建立铜臭相关风险评分的预后价值。我们的研究结果显示两组与铜凸相关。B组存在明显的孤立性先天免疫细胞浸润,预后较差,且高危组和低危组在预后和免疫浸润方面存在显著差异。高铜死亡率风险评分与肿瘤突变负担(TMB)升高和预后不良相关。我们的研究结果表明,评估铜死亡亚型有助于深入了解CRGs。此外,铜死亡率风险评分模型有助于表征预后和免疫浸润独立于TMB。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives. Application of PROTACs in Target Identification and Target Validation. PROTACs Targeting Epigenetic Proteins. Exploitation of platelets for antitumor drug delivery and modulation of the tumor immune microenvironment Emerging role of HJURP as a therapeutic target in cancers
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1